ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Advita Ortho’s next-generation knee replacement platform combines advanced polyethylene, surgeon-controlled navigation and balancing intelligence within a unified workflow.
imphoenix82
Kowa’s selective PPARα modulator “K-808” (pemafibrate) has been granted “breakthrough therapy” designation by the US FDA for the treatment of primary biliary cholangitis.
imphoenix82
Solbasium, an American company focused on science-backed red light therapy and recovery technology, has announced plans to launch the Solbasium Quantum Roller, a patented recovery device that combines myofascial rolling, tissue compression and dual red and near-infrared light therapy in a single portable system. Developed for athletes, clinicians, and wellness enthusiasts, the Quantum Roller is […]
imphoenix82
As part of the transaction, Andone founder Jay Barat joins SteriMax to lead its veterinary and medical device businesses.
imphoenix82
The Ayushman Sarathi chatbot enables beneficiaries to access essential Ayushman Bharat services anytime and anywhere, eliminating the need to visit government offices or contact call centres.
imphoenix82
Union Health Minister Jagat Prakash Nadda on Monday (June 29) launched eSushrut@Clinic, a lightweight, cloud-based Hospital Management Information System (HMIS) developed specifically for small outpatient clinics to support digital transformation across India’s healthcare sector. Developed by the Centre for Development of Advanced Computing (C-DAC), the platform aims to address inefficiencies in healthcare digitisation among small clinics […]
imphoenix82
Aarogya Setu 2.0 provides a single, citizen-centric digital gateway for accessing health services. Read on to know the key features of the updated version…
imphoenix82
“The launch of these digital health initiatives marks another important step towards making healthcare more integrated, accessible and citizen-centric,” says J P Nadda.
imphoenix82
Applications are invited under two key sub-schemes to promote domestic manufacturing and innovation in the medical devices sector.
imphoenix82
AbbVie has received a positive CHMP opinion for upadacitinib (RINVOQ) to treat adults and adolescents with severe alopecia areata and non-segmental vitiligo, with a final European Commission decision expected in the coming months.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
